X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5374) 5374
science & technology (4504) 4504
life sciences & biomedicine (4397) 4397
female (3502) 3502
antineoplastic agents, phytogenic - adverse effects (3183) 3183
male (2653) 2653
middle aged (2499) 2499
antineoplastic agents, phytogenic - administration & dosage (2498) 2498
oncology (2442) 2442
antineoplastic agents, phytogenic - therapeutic use (2296) 2296
aged (2138) 2138
adult (1919) 1919
paclitaxel - adverse effects (1399) 1399
animals (1353) 1353
antineoplastic agents, phytogenic - pharmacology (1268) 1268
treatment outcome (1193) 1193
paclitaxel - administration & dosage (1147) 1147
pharmacology & pharmacy (1131) 1131
cancer (1075) 1075
antineoplastic combined chemotherapy protocols - therapeutic use (1025) 1025
chemotherapy (973) 973
paclitaxel - therapeutic use (894) 894
breast neoplasms - drug therapy (881) 881
drug administration schedule (876) 876
paclitaxel (873) 873
camptothecin - analogs & derivatives (846) 846
antineoplastic combined chemotherapy protocols - adverse effects (761) 761
lung neoplasms - drug therapy (661) 661
antineoplastic agents, phytogenic - pharmacokinetics (652) 652
neoplasms - drug therapy (641) 641
cell line, tumor (629) 629
dose-response relationship, drug (591) 591
mice (589) 589
camptothecin - adverse effects (567) 567
infusions, intravenous (541) 541
care and treatment (537) 537
aged, 80 and over (492) 492
medicine & public health (467) 467
paclitaxel - analogs & derivatives (467) 467
taxoids (454) 454
apoptosis (453) 453
apoptosis - drug effects (448) 448
camptothecin - administration & dosage (445) 445
breast cancer (439) 439
research (427) 427
docetaxel (425) 425
carcinoma, non-small-cell lung - drug therapy (424) 424
survival analysis (421) 421
breast neoplasms - pathology (409) 409
analysis (407) 407
antineoplastic agents, phytogenic - chemistry (389) 389
irinotecan (388) 388
neutropenia - chemically induced (382) 382
vinblastine - analogs & derivatives (378) 378
antineoplastic agents (354) 354
cell proliferation - drug effects (348) 348
abridged index medicus (347) 347
camptothecin - therapeutic use (344) 344
disease-free survival (335) 335
ovarian neoplasms - drug therapy (331) 331
survival rate (325) 325
antimitotic agents (317) 317
health aspects (316) 316
antineoplastic combined chemotherapy protocols - administration & dosage (303) 303
paclitaxel - pharmacology (302) 302
drug therapy (301) 301
retrospective studies (301) 301
antineoplastic agents - administration & dosage (297) 297
adolescent (296) 296
vinblastine - adverse effects (293) 293
cisplatin - administration & dosage (289) 289
time factors (289) 289
neoplasm metastasis (287) 287
neoplasm staging (285) 285
etoposide - administration & dosage (280) 280
pharmacology/toxicology (280) 280
rats (279) 279
follow-up studies (274) 274
metastasis (269) 269
tumors (268) 268
vinblastine - administration & dosage (263) 263
administration, oral (261) 261
cell survival - drug effects (259) 259
disease progression (259) 259
antineoplastic agents - adverse effects (256) 256
plant extracts - pharmacology (254) 254
adenocarcinoma - drug therapy (253) 253
etoposide - adverse effects (252) 252
drug resistance, neoplasm (251) 251
taxoids - adverse effects (251) 251
combined modality therapy (249) 249
colorectal neoplasms - drug therapy (246) 246
vincristine - adverse effects (245) 245
prospective studies (241) 241
antimetabolites, antineoplastic - administration & dosage (239) 239
paclitaxel - pharmacokinetics (236) 236
cancer therapies (228) 228
toxicity (223) 223
lung neoplasms - pathology (219) 219
child (217) 217
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5599) 5599
Japanese (256) 256
French (71) 71
Chinese (58) 58
German (57) 57
Spanish (25) 25
Italian (21) 21
Russian (12) 12
Hungarian (7) 7
Polish (5) 5
Portuguese (3) 3
Danish (2) 2
Dutch (2) 2
Hebrew (2) 2
Czech (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer chemotherapy and pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2004, Volume 22, Issue 9, pp. 1589 - 1597
Journal Article
Journal Article
Journal Article
Journal of cellular physiology, ISSN 0021-9541, 05/2019, Volume 234, Issue 5, pp. 5728 - 5740
.... Experimental studies have shown that inflammation plays a central role in tumor resistance and the incidence of several side effects following both chemotherapy and radiotherapy... 
radiotherapy | cancer | inflammation | chemotherapy | curcumin | Physiology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neoplasms - metabolism | Drug-Related Side Effects and Adverse Reactions - prevention & control | Curcumin - therapeutic use | Signal Transduction | Humans | Risk Factors | Drug-Related Side Effects and Adverse Reactions - etiology | Drug-Related Side Effects and Adverse Reactions - metabolism | Radiotherapy - adverse effects | Curcumin - adverse effects | Radiation Injuries - etiology | Neoplasms - therapy | Animals | Anti-Inflammatory Agents - adverse effects | Radiation Injuries - prevention & control | Inflammation Mediators - metabolism | Anti-Inflammatory Agents - therapeutic use | Radiation-Protective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - therapeutic use | Radiation Injuries - metabolism | Radiation-Protective Agents - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Toxicity | Clinical trials | Tissues | Dermatitis | Cancer therapies | Metastases | Prostaglandin endoperoxide synthase | Angiogenesis | Bone marrow | Curcumin | Medical research | Mucositis | Free radicals | Cytokines | Tumor cells | Inflammation | Radiation therapy | Nitric-oxide synthase | Side effects | Chemotherapy | Pneumonitis | Nitric oxide | Fibrosis | Nuclear reactions | Cancer | Tumors | Index Medicus
Journal Article